Edgar Filing: ABBOTT LABORATORIES

Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Â Contreras Jaime

2. Date of Event Requiring Statement (Month/Day/Year)
09/16/2013

3. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ABT]

(Last)

(First)

(Middle)

100 ABBOTT PARK ROAD

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
Senior Vice President

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

ABBOTT PARK,Â ILÂ 60064

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common shares without par value	23,733	D	Â
Common shares without par value	20 ⁽¹⁾	I	Profit Sharing Trust
Common shares without par value	63,903 ⁽²⁾	I	Jaime Contreras Marvan 2006 Living Trust
Common shares without par value	2,066 ⁽³⁾	I	By spouse
Common shares without par value	16 ⁽⁴⁾	I	Profit Sharing Trust (by spouse)
Common shares without par value	12,081 ⁽⁵⁾	I	Living Trust (by spouse)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Option (right to buy) ⁽⁶⁾	02/15/2009	02/14/2018	Common shares	11,300	$ 26.7	D	Â
Option (right to buy) ⁽⁶⁾	02/15/2010	02/14/2018	Common shares	11,300	$ 26.7	D	Â
Option (right to buy) ⁽⁶⁾	02/15/2011	02/14/2018	Common shares	11,300	$ 26.7	D	Â
Option (right to buy) ⁽⁶⁾	02/20/2010	02/19/2019	Common shares	5,900	$ 26.02	D	Â
Option (right to buy) ⁽⁶⁾	02/20/2011	02/19/2019	Common shares	5,900	$ 26.02	D	Â
Option (right to buy) ⁽⁶⁾	02/20/2012	02/19/2019	Common shares	5,900	$ 26.02	D	Â
Option (right to buy) ⁽⁷⁾	02/19/2011	02/18/2020	Common shares	4,467	$ 26.19	D	Â
Option (right to buy) ⁽⁷⁾	02/19/2012	02/18/2020	Common shares	4,466	$ 26.19	D	Â
Option (right to buy) ⁽⁷⁾	02/19/2013	02/18/2020	Common shares	4,467	$ 26.19	D	Â
Option (right to buy) ⁽⁷⁾	02/18/2012	02/17/2021	Common shares	5,767	$ 22.39	D	Â
Option (right to buy) ⁽⁷⁾	02/18/2013	02/17/2021	Common shares	5,766	$ 22.39	D	Â
Option (right to buy) ⁽⁷⁾	02/18/2014	02/17/2021	Common shares	5,767	$ 22.39	D	Â
Option (right to buy) ⁽⁷⁾	02/17/2013	02/16/2022	Common shares	7,334	$ 27.03	D	Â
Option (right to buy) ⁽⁷⁾	02/17/2014	02/16/2022	Common shares	7,333	$ 27.03	D	Â
Option (right to buy) ⁽⁷⁾	02/17/2015	02/16/2022	Common shares	7,333	$ 27.03	D	Â
Option (right to buy) ⁽⁷⁾	07/15/2013	02/19/2014	Common shares	21,108	$ 33.37	D	Â
Option (right to buy) ⁽⁷⁾	02/15/2014	02/14/2023	Common shares	19,934	$ 34.94	D	Â
Option (right to buy) ⁽⁷⁾	02/15/2015	02/14/2023	Common shares	19,933	$ 34.94	D	Â
Option (right to buy) ⁽⁷⁾	02/15/2016	02/14/2023	Common shares	19,933	$ 34.94	D	Â
Option (right to buy) ⁽⁷⁾	08/20/2013	02/19/2014	Common shares	1,545	$ 35.08	D	Â
Option (right to buy) ⁽³⁾ ⁽⁶⁾	07/20/2008	07/19/2017	Common shares	1,034	$ 25.76	I	By spouse
Option (right to buy) ⁽³⁾ ⁽⁶⁾	07/20/2009	07/19/2017	Common shares	1,033	$ 25.76	I	By spouse
Option (right to buy) ⁽³⁾ ⁽⁶⁾	07/20/2010	07/19/2017	Common shares	1,033	$ 25.76	I	By spouse
Option (right to buy) ⁽³⁾ ⁽⁶⁾	02/15/2009	02/14/2018	Common shares	1,067	$ 26.7	I	By spouse
Option (right to buy) ⁽³⁾ ⁽⁶⁾	02/15/2010	02/14/2018	Common shares	1,067	$ 26.7	I	By spouse
Option (right to buy) ⁽³⁾ ⁽⁶⁾	02/15/2011	02/14/2018	Common shares	1,066	$ 26.7	I	By spouse
Option (right to buy) ⁽³⁾ ⁽⁷⁾	08/20/2013	02/19/2014	Common shares	2,715	$ 35.08	I	By spouse

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Contreras Jaime 100 ABBOTT PARK ROAD ABBOTT PARK,Â ILÂ 60064	Â	Â	Â Senior Vice President	Â

Signatures

John A. Berry, by power of attorney for Jaime Contreras		09/26/2013
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Balance in the Abbott Laboratories Stock Retirement Trust as of 9/16/13.
(2)	Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.
(3)	The reporting person disclaims beneficial ownership of all securities held by his spouse.
(4)	Balance held by spouse in the Abbott Laboratories Stock Retirement Trust as of 9/16/13. The reporting person disclaims beneficial ownership of these securities.
(5)	Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.
(6)	Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
(7)	Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.